Evaluation and Development of Annual Drug Provides Planning at the Riau Islands Province Pharmaceutical Installation

Main Article Content

Indri Ayu Ningsih
Dedy Almasdy
Alexie Herryandie Bronto Adi

Keywords

Abstract

The high value of expired drugs in the Pharmaceutical Installation of the Riau Islands Province is one of the problems that is faced in the planning process of the Provincial Buffer Stock drug provides. The study was conducted with a qualitative approach and evaluation to understand and find the answers to the problems. The results from identification of problems that were carried out through Focus Group Discussion (FGD) are the data, human resources, and supporting factors that have a significant influence in preparing the plans for drug provides. The four main scales of priority of improvement strategies that were obtained in the preparation of drug planning are (1) Technical guidance and monitoring of evaluation of human resources at the health service center are carried out periodically by the Provincial Pharmacy Installation; (2) Availability of guidelines about the types of drugs that can be provided; (3) Provision of Standard Operational Procedure (SOP) and guidelines for the preparation of written drug providers; (4) The Pharmacy Installation Managers must be pharmaceutical professionals and not be burdened with other work. In an effort to improve data validation in the preparation of the drug provides the plan in the Pharmaceutical Installation of Riau Islands Province, the SILO application (Drug Logistics Information System) is recommended.

Downloads

Download data is not yet available.

References

[1]       Dinkes Provinsi Kepulauan Riau. Profil Dinas  Kesehatan Provinsi Kepulauan Riau. Dinas Kesehatan Provinsi Kepulauan Riau, Tanjungpinang pp. 42-55, 2017.

[2]       I. N. Rumbay, “Analisis Perencanaan Obat di Dinas Kesehatan Kabupaten Minahasa Tenggara,” Master Tesis, Universitas Sam Ratulangi, Manado, 2015.   

[3]       Y. W. Waluyo, U. M. I. Athiyah, dan T. N. Rochmah, “Analisis Faktor yang Mempengaruhi Pengolaan Obat Publik di Instalasi Farmasi Kabupaten (Studi di Papua Wilayah Selatan),” Jurnal Ilmu Kefarmasian Indonesia, vol. 13(1), pp. 94-101, 2015.

[4]       S. N. Adiatmoko, “Analisis Perencanaan Kebutuhan Obat Untuk UPT. Instalasi Farmasi di Wilayah Kerja Dinas Kesehatan Kota Pangkal Pinang, TAPM,” Ph.D Thesis, Universitas Terbuka, Pangkal Pinang, 2012.

[5]       B. Jatau, Y. Avong, O. Ogundahunsi, S. Shah, and T. S. Katherine, “Procurement and supply management system for MDR-TB in Nigeria: Are the early warning targets for drug stock outs and over stock of drugs being achieved?,” PLoS One, vol. 10(6), 2015. https://doi.org/10.1371/journal.pone.0128500.

[6]       M. J. Iqbal, M. I. Geer, and P. A. Dar, “Medicines management in hospitals: a supply chain perspective,” Systematic Reviews in Pharmacy, vol. 8(1), pp. 80, 2017. https://doi.org/10.5530/srp.2017.1.14.

[7]       T. Gabriel and T. B. Tafesse, “Supply Chain Management of Antiretroviral Drugs in Public Health Facilities in Eastern Ethiopia,” Journal of Young Pharmacists, vol. 9(4), pp. 571-576, 2017. https://doi.org/10.5530/jyp.2017.9.109.

[8]       M. Yusuf, Metode Penelitian Kualitatif, Kuantitatif dan Penelitian Gabungan. Padang: Prenada Media Group, 2013, pp. 333-426.

[9]       J. J. Hanlon, Public Health: Administration and Practice. Ed.6. C.V. Mosby Company, 1974.

[10]    A. Paramita, Teknik focus group discussion dalam penelitian kualitatif (focus group discussion tehnique in qualitative research), Kebijakan Kesehatan dan Pemberdayaan Masyarakat, Badan Penelitian dan Pengembangan Kesehatan, Kementerian Kesehatan RI, 2013.

[11]    A. D. Spiegel and H. H. Hyman, Strategic Health Planning: Methods and Techniques Applied to Marketing and Management. 3rd printing. New Jersey: Ablex Publishing Corporation, 1998.

[12]    E. Indrizal, Diskusi kelompok terarah focus group discussion (FGD) (Prinsip-Prinsip dan Langkah Pelaksanaan Lapangan). Universitas Andalas, Padang, pp. 75-82, 2019.

[13]    S. P. Siagian, Sistem Informasi Manajemen. Jakarta: Bumi Aksara, 2004.

[14]    Muangchoo, S. and D. Kritchanchai, “National drug information sharing in the Thailand health care supply chain’” Therapeutic Innovation & Regulatory Science, vol. 49(6), pp. 920-928, 2015. http://dx.doi.org/10.1177/2168479015583726.

[15]    G. Gebicki, A. Andrikopoulos, M. Hume, L. Mazur, S. J. Chen, “Methods and skills for improving health care processes: a learn engineering approach,” J. Flowler and S. Mason eds., 2010. http://files.ncsu- coe.gethifi.com/publications/IERC.Gebicki-et-al.pdf.

[16]    M. D. Rosetti and Y. Liu, “Simulating Skill Proliferation in healthcare supply chain’” In M. D. Rossetti, R. R. Hill, B.  Johansson, A. Dunkin, R. G. Ingalls, eds. Proceedings of the 2009 winter simulation conference, Autin, TX:IEEE:2365-2374, 2009.

[17]    N. Shah N, “Pharmaceutical Supply Chain: key issues and strategies for optimization, ”Computers & chemical engineering, vol. 28(6-7), pp. 929-941, 2004. https://doi.org/10.1016/j.compchemeng.2003.09.022.

[18]    L. R. Burns, R. A. De Graiff, P. M. Danzon, J. R. Kimberly, W. L. Kissick, and M. V. Pauly, The Wharton school collengues.eds.: “The Health Care Value: Proceducer, Purchasers, and Providers,” San Fransisco: Jossey. Bass, pp. 3-23, 2002.